SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 35.53 |
| Enterprise Value ($M) | 35.53 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.75 |
| Net Income | -16.83 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -9.49 |
| Cash from Investing | 0.00 |
| Cash from Financing | 6.21 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,463 | 12,733 | 27.20 | |
| 3,745 | 23,500 | 15.94 | |
| 4,996 | 28,190 | 17.72 | |
| 5,747 | 58,929 | 9.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCEA – Ocean Biomedical, Inc. | OCGN – Ocugen, Inc. |
| OCX – OncoCyte Corporation | ONCO – Onconetix, Inc. |
| ONCT – Oncternal Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io